Therefore, as a transmembrane protein, CLDN12 may modulate the metastatic ability of tumor cells through regulating calcium influx, or by interacting with cadherins and influencing calcium-dependent signal transduction pathways. The gene discussed is CDH17; the disease is neoplasm.